Medcura, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-25.
Medcura, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 25, 2025. The filing reports $28.55M sold. Its industry group is Biotechnology (SEC Form D, July 25, 2025).
Is this your company?
Sell to companies like Medcura, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Medcura, Inc.
Free to see. No signup.
More on the people and the money behind Medcura, Inc., from the filings we hold.
Biotechnology raises by companies based in Maryland, filed within 90 days of this one, largest first.
Get an email when Medcura, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Medcura, Inc. raises, hires or launches. No email unless you switch it on.
Watch Medcura, Inc. →Get the full cited report on Medcura, Inc.
What the filing shows about Medcura, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Medcura, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Medcura, Inc.'s address as 5650 Rivertech Court, Suite S, Riverdale, MD 20737.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Medcura, Inc. is a registered filer with the SEC (CIK 1672180) and has filed since 2024-07-24. 2 filings are on record, the latest on 2025-07-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Medcura, Inc.'s Form D of 2025-07-25 names Jim Buck, Larry Tiffany, Matthew Dowling, Ph.D and 2 more as its officers, directors or promoters.
Its new offerings report $28.55M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
At Medcura, our breakthrough biopolymer technologies are redefining hemostasis with solutions designed to address real problems — for patients, surgeons, and payers.
The title and description the site itself served, answering 200, after redirecting from https://medcurainc.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Director, Executive Officer.
Jim Buck is named as Mr. Buck is the President and Chief Executive Officer of the Issuer. on the Form D that Medcura, Inc. filed with the SEC on 25 July 2025, one of 5 people that filing names.
On the filing as: Director, Executive Officer.
Larry Tiffany is named as Mr. Tiffany is the Executive Chairman of the Issuer. on the Form D that Medcura, Inc. filed with the SEC on 25 July 2025, one of 5 people that filing names.
On the filing as: Director, Executive Officer.
Matthew Dowling, Ph.D is named as Dr. Dowling is the Chief Scientic Officer of the Issuer. on the Form D that Medcura, Inc. filed with the SEC on 25 July 2025, one of 5 people that filing names.
On the filing as: Executive Officer.
Rich Vincent is named as Mr. Vincent is the Chief Financial Officer of the Issuer. on the Form D that Medcura, Inc. filed with the SEC on 25 July 2025, one of 5 people that filing names.
Abbas Ardehali, M.D. is named as Director on the Form D that Medcura, Inc. filed with the SEC on 25 July 2025, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2025-07-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Medcura, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Medcura, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medcura, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Medcura, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Medcura, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (medcurainc.com).
Each opens in a new tab, filled in for Medcura, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/medcura-inc-form-d-25000001